Invention Grant
- Patent Title: Hippo and dystrophin complex signaling in cardiomyocyte renewal
-
Application No.: US17096260Application Date: 2020-11-12
-
Publication No.: US11459565B2Publication Date: 2022-10-04
- Inventor: James F. Martin , Yuka Morikawa , Todd Ryan Heallen , John Leach
- Applicant: Baylor College of Medicine , Texas Heart Institute
- Applicant Address: US TX Houston; US TX Houston
- Assignee: Baylor College of Medicine,Texas Heart Institute
- Current Assignee: Baylor College of Medicine,Texas Heart Institute
- Current Assignee Address: US TX Houston; US TX Houston
- Agency: Norton Rose Fulbright US LLP
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/713 ; C12N15/86 ; C12N7/00

Abstract:
Embodiments of the disclosure include methods and compositions for the renewal of cardiomyocytes by targeting the Hippo pathway. In particular embodiments, an individual with a need for cardiomyocyte renewal is provided an effective amount of a shRNA molecule that targets the Sav1 gene. Particular shRNA sequences are disclosed.
Public/Granted literature
- US20210062190A1 HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL Public/Granted day:2021-03-04
Information query
IPC分类: